Allarity Therapeutics Announces 1-for-20 Reverse Stock
Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...
Stay updated with breaking news from Nasdaq Allr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...
Allarity Therapeutics (NASDAQ:ALLR – Get Free Report) and Applied Therapeutics (NASDAQ:APLT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation. Analyst Recommendations This is a summary of […]
Allarity Therapeutics, Inc. (NASDAQ:ALLR – Free Report) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totalling 186,300 shares, a decline of 33.6% from the May 31st total of 280,600 shares. Based on an average trading volume of 3,620,000 shares, the short-interest ratio is […]
Press Release BOSTON, MA (June 27, 2023) – Allarity Therapeutics, Inc. (NASDAQ: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical...
Allarity Therapeutics, Inc. (NASDAQ:ALLR – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 167,900 shares, an increase of 21.1% from the April 15th total of 138,700 shares. Based on an average daily trading volume, of 2,680,000 shares, the days-to-cover ratio […]